Aledade valuation, funding and investors
Aledade works in value-based care solutions development, based in Bethesda, United States. Founded in 2014, it has about 1,960 employees.
- Last round
- Series F · $260M · Jun 2023
- Valuation at last round
- $3.50B
- Headcount
- 1,955 · up
- Grade
- C
- Founded
- 2014
Aledade valuation today
VCMC values Aledade at $4.1B today, with a range of $1.2B to $5.6B and a grade of C. The valuation starts from its last funding round, a Series F round in Jun 2023.
Valuation by date (161 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2014 | $5.01M | $1.83M – $13.8M | $5.25M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2014 | $5.03M | $1.83M – $13.8M | $5.28M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2014 | $5.05M | $1.84M – $13.9M | $5.29M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2014 | $5.07M | $1.85M – $13.9M | $5.32M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2014 | $5.09M | $1.85M – $14.0M | $5.34M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2014 | $5.11M | $1.86M – $14.0M | $5.36M (+5%) | before first round | – | unknown | D | 0% |
| 19 Jun 2014 | $16.8M | $14.6M – $34.8M | $30.2M (+80%) | after a round | – | unknown | B | 0% |
| 1 Jul 2014 | $17.1M | $14.6M – $34.8M | $30.2M (+76%) | after a round | – | unknown | B | 0% |
| 1 Aug 2014 | $18.0M | $14.6M – $34.8M | $30.2M (+68%) | after a round | – | unknown | B | 0% |
| 1 Sep 2014 | $18.9M | $14.6M – $34.8M | $30.2M (+60%) | after a round | – | unknown | B | 0% |
| 1 Oct 2014 | $19.9M | $14.6M – $34.8M | $30.2M (+52%) | after a round | – | unknown | B | 0% |
| 1 Nov 2014 | $20.9M | $14.6M – $34.8M | $30.2M (+45%) | after a round | – | unknown | B | 0% |
| 1 Dec 2014 | $21.9M | $14.6M – $34.8M | $30.2M (+38%) | after a round | – | unknown | B | 0% |
| 1 Jan 2015 | $23.1M | $14.6M – $34.8M | $30.2M (+31%) | after a round | – | unknown | B | 0% |
| 1 Feb 2015 | $24.2M | $14.6M – $34.8M | $30.2M (+25%) | after a round | – | unknown | B | 0% |
| 1 Mar 2015 | $25.3M | $14.6M – $34.8M | $30.2M (+19%) | after a round | – | unknown | B | 0% |
| 1 Apr 2015 | $26.6M | $14.6M – $34.8M | $30.2M (+13%) | after a round | – | unknown | B | 0% |
| 1 May 2015 | $28.0M | $14.6M – $34.8M | $30.2M (+8%) | after a round | – | unknown | B | 0% |
| 1 Jun 2015 | $29.4M | $14.6M – $34.8M | $30.2M (+3%) | after a round | – | unknown | B | 0% |
| 16 Jun 2015 | $111M | $78.4M – $237M | $167M (+50%) | after a round | – | unknown | B | 0% |
| 1 Jul 2015 | $113M | $78.4M – $237M | $167M (+47%) | after a round | – | unknown | B | 0% |
| 1 Aug 2015 | $117M | $78.4M – $237M | $167M (+42%) | after a round | – | unknown | B | 0% |
| 1 Sep 2015 | $121M | $78.4M – $237M | $167M (+38%) | after a round | – | unknown | B | 0% |
| 1 Oct 2015 | $125M | $78.4M – $237M | $167M (+33%) | after a round | – | unknown | B | 0% |
| 1 Nov 2015 | $130M | $78.4M – $237M | $167M (+29%) | after a round | – | unknown | B | 0% |
| 1 Dec 2015 | $134M | $78.4M – $237M | $167M (+24%) | after a round | – | unknown | B | 0% |
| 1 Jan 2016 | $139M | $78.4M – $237M | $167M (+20%) | after a round | – | unknown | B | 0% |
| 1 Feb 2016 | $144M | $78.4M – $237M | $167M (+16%) | after a round | – | unknown | B | 0% |
| 1 Mar 2016 | $148M | $78.4M – $237M | $167M (+12%) | after a round | – | unknown | B | 0% |
| 1 Apr 2016 | $154M | $78.4M – $237M | $167M (+9%) | after a round | – | unknown | B | 0% |
| 1 May 2016 | $159M | $78.4M – $237M | $167M (+5%) | after a round | – | unknown | B | 0% |
| 1 Jun 2016 | $164M | $78.4M – $237M | $167M (+1%) | after a round | – | unknown | B | 0% |
| 1 Jul 2016 | $167M | $76.5M – $237M | $167M (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2016 | $167M | $73.2M – $237M | $167M (0%) | after a round | – | unknown | B | 0% |
| 1 Sep 2016 | $167M | $70.0M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $167M | $67.1M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $167M | $64.2M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $167M | $61.5M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $167M | $58.9M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $167M | $56.3M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $167M | $54.1M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $167M | $51.8M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $167M | $49.6M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $167M | $47.5M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $167M | $41.9M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $167M | $39.8M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $167M | $37.8M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $167M | $36.0M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $167M | $34.2M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $167M | $32.6M – $237M | $167M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $167M | $30.9M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2018 | $167M | $29.4M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2018 | $167M | $28.1M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2018 | $167M | $26.7M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2018 | $167M | $25.4M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2018 | $167M | $24.1M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2018 | $167M | $23.0M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2018 | $167M | $21.8M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2018 | $167M | $20.8M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2018 | $167M | $19.8M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2018 | $167M | $18.8M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2018 | $167M | $17.9M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2019 | $167M | $17.0M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2019 | $167M | $16.1M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2019 | $167M | $15.4M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2019 | $167M | $14.7M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2019 | $167M | $13.9M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2019 | $167M | $13.3M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2019 | $167M | $12.6M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2019 | $167M | $12.0M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2019 | $167M | $11.4M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2019 | $167M | $10.8M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2019 | $167M | $10.3M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2019 | $167M | $9.81M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2020 | $167M | $9.33M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2020 | $167M | $8.86M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2020 | $167M | $8.45M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2020 | $167M | $8.03M – $237M | $167M (0%) | after a round | – | unknown | D | 0% |
| 21 Apr 2020 | $582M | $382M – $1.2B | $756M (+30%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $586M | $382M – $1.2B | $756M (+29%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $600M | $382M – $1.2B | $756M (+26%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $613M | $382M – $1.2B | $756M (+23%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $626M | $382M – $1.2B | $756M (+21%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $641M | $382M – $1.2B | $756M (+18%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $655M | $382M – $1.2B | $756M (+16%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $669M | $382M – $1.2B | $756M (+13%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $684M | $382M – $1.2B | $756M (+11%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $699M | $382M – $1.2B | $756M (+8%) | after a round | – | unknown | B | 0% |
| 20 Jan 2021 | $2.1B | $1.8B – $3.1B | $2.7B (+30%) | after a round | – | unknown | A | 0% |
| 1 Feb 2021 | $2.1B | $1.8B – $3.1B | $2.7B (+29%) | after a round | – | unknown | A | 0% |
| 1 Mar 2021 | $2.2B | $1.8B – $3.1B | $2.7B (+26%) | after a round | – | unknown | A | 0% |
| 1 Apr 2021 | $2.2B | $1.8B – $3.1B | $2.7B (+23%) | after a round | – | unknown | A | 0% |
| 1 May 2021 | $2.3B | $1.8B – $3.1B | $2.7B (+21%) | after a round | – | unknown | A | 0% |
| 1 Jun 2021 | $2.3B | $1.8B – $3.1B | $2.7B (+18%) | after a round | – | unknown | A | 0% |
| 1 Jul 2021 | $2.4B | $1.8B – $3.1B | $2.7B (+16%) | after a round | – | unknown | A | 0% |
| 1 Aug 2021 | $2.4B | $1.8B – $3.1B | $2.7B (+13%) | after a round | – | unknown | A | 0% |
| 1 Sep 2021 | $2.5B | $1.8B – $3.1B | $2.7B (+11%) | after a round | – | unknown | A | 0% |
| 1 Oct 2021 | $2.5B | $1.8B – $3.1B | $2.7B (+8%) | after a round | – | unknown | A | 0% |
| 1 Nov 2021 | $2.6B | $1.8B – $3.1B | $2.7B (+6%) | after a round | – | unknown | A | 0% |
| 1 Dec 2021 | $2.6B | $1.8B – $3.1B | $2.7B (+4%) | after a round | – | unknown | A | 0% |
| 1 Jan 2022 | $2.7B | $1.8B – $3.1B | $2.7B (+1%) | after a round | – | unknown | A | 0% |
| 1 Feb 2022 | $2.7B | $1.8B – $3.1B | $2.7B (0%) | after a round | – | unknown | A | 0% |
| 1 Mar 2022 | $2.7B | $1.7B – $3.1B | $2.7B (0%) | after a round | – | unknown | B | 0% |
| 1 Apr 2022 | $2.7B | $1.6B – $3.1B | $2.7B (0%) | after a round | – | unknown | B | 0% |
| 1 May 2022 | $2.7B | $1.6B – $3.1B | $2.7B (0%) | after a round | – | unknown | B | 0% |
| 1 Jun 2022 | $2.7B | $1.5B – $3.1B | $2.7B (0%) | after a round | – | unknown | B | 0% |
| 7 Jun 2022 | $3.1B | $2.7B – $4.6B | $4.0B (+30%) | after a round | – | unknown | A | 0% |
| 1 Jul 2022 | $3.2B | $2.7B – $4.6B | $4.0B (+28%) | after a round | – | unknown | A | 0% |
| 1 Aug 2022 | $3.2B | $2.7B – $4.6B | $4.0B (+25%) | after a round | – | unknown | A | 0% |
| 1 Sep 2022 | $3.3B | $2.7B – $4.6B | $4.0B (+22%) | after a round | – | unknown | A | 0% |
| 1 Oct 2022 | $3.4B | $2.7B – $4.6B | $4.0B (+20%) | after a round | – | unknown | A | 0% |
| 1 Nov 2022 | $3.4B | $2.7B – $4.6B | $4.0B (+17%) | after a round | – | unknown | A | 0% |
| 1 Dec 2022 | $3.5B | $2.7B – $4.6B | $4.0B (+14%) | after a round | – | unknown | A | 0% |
| 1 Jan 2023 | $3.6B | $2.7B – $4.6B | $4.0B (+12%) | after a round | – | unknown | A | 0% |
| 1 Feb 2023 | $3.7B | $2.7B – $4.6B | $4.0B (+9%) | after a round | – | unknown | A | 0% |
| 1 Mar 2023 | $3.8B | $2.7B – $4.6B | $4.0B (+7%) | after a round | – | unknown | A | 0% |
| 1 Apr 2023 | $3.8B | $2.7B – $4.6B | $4.0B (+5%) | after a round | – | unknown | A | 0% |
| 1 May 2023 | $3.9B | $2.7B – $4.6B | $4.0B (+3%) | after a round | – | unknown | A | 0% |
| 1 Jun 2023 | $4.0B | $2.7B – $4.6B | $4.0B (0%) | after a round | – | unknown | A | 0% |
| 21 Jun 2023 | $3.5B | $3.0B – $5.2B | $4.6B (+30%) | after a round | – | unknown | A | 0% |
| 1 Jul 2023 | $3.5B | $3.0B – $5.2B | $4.6B (+29%) | after a round | – | unknown | A | 0% |
| 1 Aug 2023 | $3.6B | $3.0B – $5.2B | $4.6B (+26%) | after a round | – | unknown | A | 0% |
| 1 Sep 2023 | $3.7B | $3.0B – $5.2B | $4.6B (+23%) | after a round | – | unknown | A | 0% |
| 1 Oct 2023 | $3.8B | $3.0B – $5.2B | $4.6B (+21%) | after a round | 1,300 | unknown | A | 0% |
| 1 Nov 2023 | $3.9B | $3.0B – $5.2B | $4.6B (+18%) | after a round | 1,300 | unknown | A | 0% |
| 1 Dec 2023 | $3.9B | $3.0B – $5.2B | $4.6B (+16%) | after a round | 1,300 | unknown | A | 0% |
| 1 Jan 2024 | $4.0B | $3.0B – $5.2B | $4.6B (+13%) | after a round | 1,300 | unknown | A | 0% |
| 1 Feb 2024 | $4.2B | $3.0B – $5.3B | $4.6B (+11%) | after a round | 1,400 | flat | A | 0% |
| 1 Mar 2024 | $4.3B | $3.0B – $5.3B | $4.6B (+9%) | after a round | 1,400 | flat | A | 0% |
| 1 Apr 2024 | $4.4B | $3.0B – $5.3B | $4.6B (+6%) | after a round | 1,400 | flat | A | 0% |
| 1 May 2024 | $4.5B | $3.0B – $5.3B | $4.6B (+4%) | after a round | 1,400 | flat | A | 0% |
| 1 Jun 2024 | $4.6B | $3.0B – $5.3B | $4.6B (+1%) | after a round | 1,400 | flat | A | 0% |
| 1 Jul 2024 | $4.6B | $3.0B – $5.3B | $4.6B (0%) | after a round | 1,400 | flat | A | 0% |
| 1 Aug 2024 | $4.7B | $3.0B – $5.4B | $4.7B (0%) | after a round | 1,500 | up | A | 0% |
| 1 Sep 2024 | $4.7B | $3.0B – $5.4B | $4.7B (0%) | after a round | 1,500 | up | A | 0% |
| 1 Oct 2024 | $4.7B | $3.0B – $5.4B | $4.7B (0%) | after a round | 1,500 | up | B | 0% |
| 1 Nov 2024 | $4.8B | $2.9B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Dec 2024 | $4.8B | $2.9B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Jan 2025 | $4.8B | $2.9B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Feb 2025 | $4.8B | $2.9B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Mar 2025 | $4.8B | $2.9B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Apr 2025 | $4.8B | $2.8B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 May 2025 | $4.8B | $2.8B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Jun 2025 | $4.8B | $2.8B – $5.5B | $4.8B (0%) | after a round | 1,600 | up | B | 0% |
| 1 Jul 2025 | $4.8B | $2.6B – $5.5B | $4.8B (0%) | after a round | 1,686 | up | B | 0% |
| 1 Aug 2025 | $4.8B | $2.5B – $5.5B | $4.8B (0%) | after a round | 1,688 | up | B | 0% |
| 1 Sep 2025 | $4.8B | $2.5B – $5.5B | $4.8B (-1%) | after a round | 1,688 | up | B | 0% |
| 1 Oct 2025 | $4.8B | $2.4B – $5.6B | $4.8B (-2%) | after a round | 1,710 | up | B | 0% |
| 1 Nov 2025 | $4.8B | $2.4B – $5.6B | $4.7B (-2%) | after a round | 1,710 | up | B | 0% |
| 1 Dec 2025 | $4.9B | $2.3B – $5.6B | $4.7B (-2%) | after a round | 1,741 | up | B | 0% |
| 1 Jan 2026 | $4.9B | $2.3B – $5.6B | $4.7B (-3%) | after a round | 1,741 | up | B | 0% |
| 1 Feb 2026 | $4.9B | $2.3B – $5.6B | $4.7B (-3%) | after a round | 1,741 | up | B | 0% |
| 1 Mar 2026 | $4.9B | $1.2B – $5.6B | $4.6B (-5%) | after a round | 1,741 | flat | C | 0% |
| 1 Apr 2026 | $4.9B | $2.2B – $5.7B | $4.7B (-4%) | after a round | 1,855 | up | B | 0% |
| 1 May 2026 | $4.9B | $2.2B – $5.7B | $4.7B (-5%) | after a round | 1,855 | up | B | 0% |
| 1 Jun 2026 | $4.9B | $1.0B – $5.7B | $4.6B (-6%) | after a round | 1,855 | flat | C | 0% |
| 1 Jul 2026 | $4.9B | $973M – $5.6B | $4.6B (-7%) | after a round | 1,855 | flat | C | 0% |
| 1 Aug 2026 | $4.9B | $925M – $5.6B | $4.6B (-7%) | after a round | 1,855 | flat | C | 0% |
| 1 Sep 2026 | $4.9B | $879M – $5.6B | $4.5B (-7%) | after a round | 1,855 | flat | C | 0% |
| 1 Oct 2026 | $4.9B | $1.5B – $5.6B | $4.7B (-5%) | after a round | 1,955 | up | C | 0% |
| 24 Oct 2026 | $4.1B | $1.2B – $5.6B | $3.9B (-4%) | after a round | 1,955 | up | C | 0% |
Key facts about Aledade
- Founded
- 2014
- Headquarters
- Bethesda, United States
- Employees
- about 1,960 +14% in a year
- Total raised
- $1.08B
- Funding rounds
- 7
- Last round
- Debt Dec 2025
Aledade was founded in 2014 by Farzad Mostashari and Mat Kendall.
Aledade funding history
Aledade has 7 funding rounds on record, from Jun 2014 to Dec 2025, $1.08B in total. The latest disclosed valuation is $3.50B post-money (Series F, Jun 2023).
Debt 1 Dec 2025no round page
Led by Ares Commercial Finance, Ares Credit funds.
Sources: aledade.com, beckerspayer.com, fiercehealthcare.com
$500M
Series F 20 Jun 2023
Led by Lightspeed Venture Partners; with Venrock, Avidity Partners, OMERS Private Equity, Fidelity Management & Research Company.
Sources: aledade.com, fiercehealthcare.com, mobihealthnews.com and 4 more
$260M
$3.50B post-money
Series E 6 Jun 2022
Led by OMERS Private Equity; with Fidelity Management & Research Company.
Sources: prnewswire.com, omersprivateequity.com, fiercehealthcare.com and 3 more
$123M
$3.10B post-money
Series D 19 Jan 2021
Led by Meritech Capital; with Tiger Global, Institutional Venture Partners, OMERS Private Equity.
Sources: prnewswire.com, finsmes.com
$100M
$2.10B post-money
Series C 20 Apr 2020
Led by OMERS Growth Equity; with California Medical Association, Meritech Capital, Echo Health Ventures, CVF Capital Partners, GV.
Sources: prnewswire.com, omersprivateequity.com, medcitynews.com
$64M
Series B 15 Jun 2015
Led by ARCH Venture Partners; with Venrock.
Sources: healthcareittoday.com, beckershospitalreview.com, hitconsultant.net and 1 more
$30M
Series A 18 Jun 2014
Led by Venrock.
$5.0M
$17M post-money
Aledade investors
16 investors have backed Aledade; OMERS Private Equity, Venrock and Meritech Capital and 5 more led at least one round.
- Venrock lead, 3 rounds
- Meritech Capital lead, 2 rounds
- ARCH Venture Partners lead
- Ares Commercial Finance lead
- Ares Credit funds lead
- Lightspeed Venture Partners lead
- OMERS Growth Equity lead
- Fidelity Management & Research Company 2 rounds
- Avidity Partners
- California Medical Association
- GV
- Institutional Venture Partners
- Tiger Global
What Aledade does
Aledade works in health care services, with 14 recorded offerings and customers in healthcare.
Aledade, Inc. is a U.S. public benefit corporation that provides technology and support services for primary care organizations, particularly in value-based care models. The company offers a cloud-based Population Health Management Platform that integrates data from multiple sources to improve care quality and cost management, along with care planning, patient outreach programs, and technology tools to support workflow adoption. Aledade also functions as a health consultant, offering data analysis, health care policy guidance, and payer relationship management. The company serves primary care organizations, community health centers, and accountable care organizations across 46 states and the District of Columbia.
Description from Veridion's company data.
Products and services
- Value-Based Care Solutions Development
- Accountable Care Organization Management
- Population Health Management Platform Development
- Primary Care Workflow Technology Solutions
- Care Planning Services
- Health Data Integration Services
- Common Record Access Solutions
- Billing and Coding Insights Services
- Health Policy Consulting Services
- Clinical Coaching Services
- Integrated Care Solutions Development
- Revenue Optimization Consulting
- Patient Outcome Improvement Services
- Sustainable Revenue Strategy Consulting
Markets
- Healthcare
Technology
- Cloud Computing for Population Health Management
Business model
- Business-to-Business
- Service Provider
- Software-as-a-Service
- Enterprise
Industry codes (NAICS)
- 541611 Administrative Management and General Management Consulting Services 50% match
- 513210 Software Publishers 50% match
Questions about Aledade
What is Aledade worth?
Valuation $4.1B (range $1.2B to $5.6B), as of 24 Oct 2026. The last disclosed valuation was $3.50B (Series F, Jun 2023).
Has Aledade raised money?
Aledade has 7 funding rounds on record, from Jun 2014 to Dec 2025, $1.08B in total. The latest disclosed valuation is $3.50B post-money (Series F, Jun 2023).
Who has invested in Aledade?
OMERS Private Equity, Venrock, Meritech Capital, ARCH Venture Partners, Ares Commercial Finance and Ares Credit funds, and 10 more. Lead investors include OMERS Private Equity, Venrock, Meritech Capital and ARCH Venture Partners.
How many people work at Aledade?
About 1,960, up 14% over the last year. Headcount grew from 1,300 in Oct 2023 to 1,955 in Sep 2026.
What does Aledade do?
Aledade works in health care services, with 14 recorded offerings and customers in healthcare. Its main offerings are value-based care solutions development, accountable care organization management and population health management platform development.
When was Aledade founded, and where is it based?
Aledade was founded in 2014 and is based in Bethesda, United States. It has about 1,960 employees, up 14% over the last year.